Recordati | REC - Cost Of Sales

Stock Price
48.42
Daily Change
0.12 0.25%
Monthly
5.26%
Yearly
-10.83%
Q1 Forecast
46.71

Recordati reported EUR199.91M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Almirall EUR 191.5M 2.29M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
Hikma Pharmaceutical USD 466.5M 428.5M Jun/2025
Orion EUR 186.6M 17.6M Dec/2025
Sanofi EUR 4.29B 421M Dec/2025